DuPont reports Q4 net loss of USD 108 million and Q4 operating EBITDA of USD 409 million

Reuters
02/10
DuPont reports Q4 net loss of USD 108 million and Q4 operating EBITDA of USD 409 million

DuPont reported its fourth quarter (Q4) and full year (FY) 2025 financial results, exceeding its previously issued guidance. For Q4 2025, DuPont posted net sales of USD 1.7 billion, which were flat compared to the prior year period. Organic sales decreased by 1 percent, including a USD 30 million headwind from a timing shift between the third and fourth quarters. The company reported a GAAP loss from continuing operations of USD 108 million for the quarter, with operating EBITDA at USD 409 million. GAAP earnings per share $(EPS)$ from continuing operations stood at negative USD 0.27, while adjusted EPS was USD 0.46. Cash provided by operating activities from continuing operations was USD 87 million, which included USD 228 million of separation-related transaction costs and other payments. Transaction-adjusted free cash flow for the quarter was USD 228 million. For the full year (FY) 2025, DuPont's net sales reached USD 6.8 billion, marking a 2 percent increase year-over-year. Organic sales also rose 2 percent, with growth supported by a currency tailwind of about 1 percent. The company highlighted ongoing impacts from separation-related costs, including USD 144 million for interest rate swap settlements and debt exchange fees aimed at achieving the post-spin capital structure, as well as USD 16 million in separation-related capital expenditures. Looking ahead, DuPont initiated first quarter and full year 2026 guidance, projecting first quarter net sales to benefit from approximately 2 percent organic growth and a 2 percent currency tailwind on a year-over-year basis. The company also addressed significant items impacting results, including internal restructurings related to its Electronics Separation, plant line closures within the Healthcare & Water segment, and the effects of international tax audits.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DuPont de Nemours Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH84302) on February 10, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10